Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:3/31/2008

First Quarter 2008 Earnings Conference Call Thursday, May 1, 2008, 5:00

p.m. U.S. EDT

FRAZER, Pa., March 31 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering first quarter 2008 results for 5:00 p.m. EDT on Thursday, May 1, 2008.

May 1, 2008 Schedule

4:10 p.m. EDT Q1 2008 results will be distributed by PRNewswire

4:50 p.m. EDT To participate in the conference call, dial 913-981-5581

and refer to Conference Code Number 7561641

5:00 p.m. EDT Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at http://www.cephalon.com and clicking on "Investor Information" then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EDT, May 14, 2008. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 7561641.

Additional information presented on the conference call may be made available on the Investor Information page of the company's website.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
2. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
3. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
4. Cephalon General Counsel John E. Osborn to Resign Position
5. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
6. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
7. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Submits Supplemental New Drug Application for FENTORA
10. Cephalon Announces Strong Third Quarter Financial Results
11. Cephalon Quarterly Conference Call Invitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)...   Pulmatrix, Inc . (NASDAQ: PULM ... therapies to address serious pulmonary diseases, today announced that ... lungs of CF patients, PUR1900, has been designated as ... Food & Drug Administration. Under the ... development of novel drugs against important pathogens, Pulmatrix will ...
(Date:1/17/2017)...  Northwell Health today announced a collaboration with ... research. As New ... Northwell Health diagnoses and treats 19,000 new cancer ... Germany -based oncology research company working ... greatly expand cancer biobanking activities within Northwell Health ...
(Date:1/17/2017)... and Hong Kong (PRWEB) , ... January 17, ... ... lifecycle management software, and NetDimensions, a global provider of learning and performance management ... agreement for the mainland China market. , “In the life sciences industry, organizations ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... laws precedential publication its decision on the appeal filed by India-based Dishman Pharmaceutical ... breach of contract against DPCL and one of its Dishman Group’s 100% wholly ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
Breaking Biology News(10 mins):